Revelation Biosciences, Inc.
REVB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001810560
No open-market purchases or sales by Revelation Biosciences, Inc. insiders were filed in the last 90 days; 12 institutions reported holding it in 13F filings for Q2 2026, worth $313.2K in total; no superinvestor holds it.
Other share classesREVBW
Q2 2022 vs. Q1 2022
How the institutions holding Revelation Biosciences, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 16 | 12 | −4 |
| Shares | 3.02M | 3.22M | +201.5K (+6.7%) |
| Value | $3.44M | $3.57M | +$135.2K (+3.9%) |
New holders (1)
Institutions that held Revelation Biosciences, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| CWM, LLC | 4,360 | $5.00K | 0.00% |
Sold out (5)
Institutions that held Revelation Biosciences, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Citadel Advisors LLC | 42,633 | $49.0K |
| Two Sigma Investments, LP | 32,540 | $37.0K |
| Ergoteles LLC | 22,327 | $25.0K |
| Jane Street Group, LLC | 19,536 | $22.0K |
| Virtu Financial LLC | 14,906 | $17.0K |